Page last updated: 2024-11-02

pentoxifylline and Astrocytoma, Grade IV

pentoxifylline has been researched along with Astrocytoma, Grade IV in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Six human glioblastoma cell lines were tested for the effect of pentoxifylline treatment at maximum G2/M block on the basis of cell survival, mitotic activity, and micronucleus formation after exposure to gamma radiation."3.79In vitro radiosensitization by pentoxifylline does not depend on p53 status. ( Akudugu, JM; Böhm, LJ; Serafin, AM, 2013)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akudugu, JM1
Serafin, AM1
Böhm, LJ1
Sperduto, PW1
Song, CW1
Levitt, SH1
Stewart, DJ1
Dahrouge, S1
Agboola, O1
Girard, A1

Trials

1 trial available for pentoxifylline and Astrocytoma, Grade IV

ArticleYear
Cranial radiation and concomitant cisplatin and mitomycin-C plus resistance modulators for malignant gliomas.
    Journal of neuro-oncology, 1997, Volume: 32, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta Carotene; Brain Neoplasms; Cisplat

1997

Other Studies

2 other studies available for pentoxifylline and Astrocytoma, Grade IV

ArticleYear
In vitro radiosensitization by pentoxifylline does not depend on p53 status.
    International journal of radiation biology, 2013, Volume: 89, Issue:6

    Topics: Cell Line, Tumor; Cell Survival; Glioblastoma; Humans; Pentoxifylline; Radiation Tolerance; Radiatio

2013
The in vitro radiosensitization of human glioblastoma with pentoxifylline.
    American journal of clinical oncology, 1993, Volume: 16, Issue:5

    Topics: Cell Survival; Glioblastoma; Humans; Pentoxifylline; Radiation-Protective Agents; Radiation-Sensitiz

1993